<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29898141</article-id><article-id pub-id-type="pmc">5985838</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0071</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Selenium, Vitamin C and N-Acetylcysteine do not Reduce the Risk of
Acute Kidney Injury after Off-Pump CABG: a Randomized Clinical
Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Amini</surname><given-names>Shahram</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Robabi</surname><given-names>Hojat Naghavi</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Tashnizi</surname><given-names>Mohammad Abbasi</given-names></name><xref ref-type="aff" rid="aff3">3</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Vakili</surname><given-names>Vida</given-names></name><xref ref-type="aff" rid="aff4">4</xref><role>MD</role></contrib></contrib-group><aff id="aff1"><label>1</label> Department of Anesthesia, Faculty of Medicine, Mashhad
University of Medical Sciences, Mashhad, Iran.</aff><aff id="aff2"><label>2</label> Department of Anesthesiology and Critical Care, Mashhad
University of Medical Sciences, Mashhad, Iran.</aff><aff id="aff3"><label>3</label> Department of Cardiac Surgery, Mashhad University of
Medical Sciences, Mashhad, Iran.</aff><aff id="aff4"><label>4</label> Department of Community Medicine, Mashhad University of
Medical Sciences, Mashhad, Iran.</aff><author-notes><corresp id="c1">Correspondence Address: Shahram Amini, Emam Reza Hospital, Cardiac
Anesthesia Research Center, Department of Anesthesiology and Critical Care, Ebne
Sina Street, Mashhad, Iran. E-mail: <email>aminish@mums.ac.ir</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Mar-Apr</season><year>2018</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2018</year></pub-date><volume>33</volume><issue>2</issue><fpage>129</fpage><lpage>134</lpage><history><date date-type="received"><day>05</day><month>4</month><year>2017</year></date><date date-type="accepted"><day>04</day><month>7</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>The aim of this study was to investigate the impact of perioperative
administration of N-acetylcysteine, selenium and vitamin C on the incidence
and outcomes of acute kidney injury after off-pump coronary bypass graft
surgery.</p></sec><sec><title>Methods</title><p>291 patients requiring elective off-pump coronary bypass graft surgery were
randomized to receive either N-acetylcysteine, vitamin C and selenium 600
mg, 1500 mg, 0.5 mg, and nothing orally twice a day, respectively, from the
day before to 2 days after surgery. They were assessed for the development
of acute kidney injury using Acute Kidney Injury Network criteria, time of
onset, its severity and duration, duration of mechanical ventilation,
intensive care unit and hospital length of stay, and in-hospital
mortality.</p></sec><sec><title>Results</title><p>272 patients completed the study. The total incidence of acute kidney injury
was 22.1% (n=60) with 14 (20.9%), 15 (22.1%), 21 (31.8%), and 10 (14.1%)
patients in the vitamin C, NAC, selenium, and control groups, respectively
(<italic>P</italic>=0.096). We did not register significant differences
in the incidence, the time of occurrence, the severity and the duration of
acute kidney injury, as well as the duration of mechanical ventilation, the
intensive care unit and hospital length of stay, and the in-hospital
mortality among the four groups.</p></sec><sec><title>Conclusion</title><p>We found that perioperative administration of N-acetylcysteine, vitamin C and
selenium were not effective in preventing acute kidney injury and associated
morbidity and mortality after off-pump coronary bypass graft surgery.</p></sec></abstract><kwd-group><kwd>Acetylcysteine</kwd><kwd>Selenium</kwd><kwd>Ascorbic Acid</kwd><kwd>Acute Kidney Injury</kwd><kwd>Coronary Artery Bypass, Off-pump</kwd></kwd-group></article-meta></front><body><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="43%" span="1"/><col width="4%" span="1"/><col width="5%" span="1"/><col width="43%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" colspan="2" style="background-color:#e6e7e8" rowspan="1">&#x000a0;</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AKI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Acute kidney injury</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ICU</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Intensive care unit</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AKIN</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Acute Kidney Injury
Network</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">K</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Potassium</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">BS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Blood sugar</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LOS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Length of stay</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">Ca</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Calcium</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">MAP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Mean arterial
pressure</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
graft surgery</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">Mg</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Magnesium</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CBC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Complete blood
count</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">Na</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Sodium</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CHF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Congestive heart
failure</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">NAC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= N-acetylcysteine</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CIN</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Contrast-induced
nephropathy</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">NYHA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= New York Heart
Association</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">COPD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Chronic obstructive
pulmonary disease</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Pressure support</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiopulmonary
bypass</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PUFA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Polyunsaturated fatty
acids</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">Cr</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Creatinine</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">RBC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Red blood cells</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">eGFR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Estimated glomerular
filtration rate</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">RRT</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Renal replacement
therapy</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">EuroSCORE</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= European System for
Cardiac Operative Risk Evaluation</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SIMV</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Synchronized
intermittent mandatory ventilation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">Hb</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Hemoglobin level</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ScVO<sub>2</sub></td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Central venous oxygen
saturation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">IABP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Intra-aortic balloon
counterpulsation</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Acute kidney injury (AKI) is frequently seen after cardiac surgery with dramatically
increased mortality and morbidity. Cardiac surgery is the second most common cause
of AKI in intensive care units (ICU)<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. The incidence has been reported 0.3% to 29.7%,
depending on the definition and the population under study<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>]</sup>, with 1.2-3% requiring
renal replacement therapy (RRT) that further increases
mortality<sup>[<xref rid="r4" ref-type="bibr">4</xref>-<xref rid="r6" ref-type="bibr">6</xref>]</sup>.</p><p>A number of measures have been proposed to prevent the development of AKI, including
maintenance of intravascular volume and adequate perfusion, and avoidance of
nephrotoxic drugs<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>.</p><p>Several drugs, including calcium channel blockers<sup>[<xref rid="r8" ref-type="bibr">8</xref>-<xref rid="r10" ref-type="bibr">10</xref>]</sup>, and
statins<sup>[<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r12" ref-type="bibr">12</xref>]</sup> have been used to prevent AKI after cardiac
surgery, but with controversial results.</p><p>Prevention of oxidative stress by antioxidants can help prevent kidney
damage<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>. The beneficial role of antioxidants in prevention
of AKI in different scenarios has been demonstrated in animal
models<sup>[<xref rid="r14" ref-type="bibr">14</xref>-<xref rid="r17" ref-type="bibr">17</xref>]</sup> and human models<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>. However, its
effectiveness in preventing AKI following cardiac surgery has not been
established<sup>[<xref rid="r19" ref-type="bibr">19</xref>-<xref rid="r21" ref-type="bibr">21</xref>]</sup>.</p><p>The purpose of this clinical trial was to investigate the role of N-acetylcysteine
(NAC), vitamin C, and selenium in prevention of AKI following off-pump coronary
artery bypass graft surgery (CABG). The primary outcome was to explore the incidence
of AKI. Secondary outcomes included comparing AKI severity, time of occurrence and
duration of AKI, need for RRT, duration of mechanical ventilation, ICU and hospital
length of stay (LOS), and related in-hospital mortality among the four groups.</p></sec><sec sec-type="methods"><title>METHODS</title><p>After obtaining approval from the university's Committee of Ethics and written
informed consent, 291 adult patients with New York Heart Association (NYHA) class of
I-III undergoing elective off-pump CABG at a teaching hospital were recruited for
this clinical trial. Exclusion criteria were change from off-pump to on-pump
surgery, known drug allergy, history of chronic obstructive pulmonary disease
(COPD), anemia, congestive heart failure (CHF), active sepsis, preoperative ejection
fraction lower than 40%, preoperative creatinine above 1.3 mg/dL, use of any
nephrotoxic drugs within the last week, coronary angiography within the last 2 days,
intraoperative transfusion of more than 2 units of red blood cells (RBC),
perioperative use of intra-aortic balloon counterpulsation (IABP), perioperative
requirement for high-dose vasopressors (defined as the use of two or more drugs to
maintain adequate mean arterial pressure and perfusion, <italic>i.e.</italic>
epinephrine or norepinephrine above 0.5 &#x000b5;g/kg/min, dobutamine or dopamine
more than 20 &#x000b5;g/kg/min), and any intraoperative life-threatening events such
as fatal arrhythmias, excessive bleeding, or desaturation.</p><p>Using a computer-based randomization method, patients received either selenium
(n=72), vitamin C (n=73), NAC (n=73), or nothing (n=73). Patients in the selenium,
vitamin C, and NAC groups received 0.5 mg, 1500 mg, and 600 mg tablets,
respectively, twice a day, from 24 hours before the operation until two
postoperative days.</p><p>Patients underwent standard intravenous anesthesia and were transferred to ICU for
post-cardiac surgery for further monitoring and recovery, where they were under a
standard monitoring and meticulous observation of a single intensive and critical
care residents and fellows per shift to maintain adequate cerebral, cardiovascular,
pulmonary, and renal function. A protocolized goal-directed fluid therapy with
normal saline solution was conducted to achieve a mean arterial pressure (MAP)
greater than 70 mmHg, lactate less than 2 mmol/L, central venous oxygen saturation
(ScVO<sub>2</sub>) greater than 70%, and urine output greater than 1 mL/kg/hour.
RBCs were transfused if hemoglobin level (Hb) was less than 8 g/dL, or Hb less than
10 mmHg in case of lactate &#x0003e; 4 mmol/L, ScVO<sub>2</sub> &#x0003c; 70%, or requiring
vasopressors or inotropes to keep MAP &#x0003e; 70 mmHg.</p><p>A protocolized intravenous paracetamol and fentanyl were used to control
postoperative pain. Patients were under mechanical ventilation after entering ICU
with synchronized intermittent mandatory ventilation (SIMV) and pressure support
(PS) mode and weaned and extubated according to a standard weaning protocol.</p><p>Complete blood count (CBC), blood sugar (BS), sodium (Na), potassium (K), magnesium
(Mg), urea, creatinine (Cr), albumin, calcium (Ca) and phosphorus were measured
preoperatively. Arterial blood gases, BS, Na, K, Ca, lactate, ScVO<sub>2</sub>, and
CBC were measured postoperatively in the first 24 hours as needed. BS, urea, Cr, Na,
K and CBC were measured daily after the operation. Urine output was measured per
hour during ICU stay.</p><p>AKI was diagnosed and scored based on Acute Kidney Injury Network (AKIN), defined as
a serum Cr increase of 0.3 mg/dL or &#x02265; 1.5 times baseline within 48 hours
(<xref ref-type="table" rid="t1">Table 1</xref>) (<ext-link ext-link-type="uri" xlink:href="www.akinet.org">www.akinet.org</ext-link>).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>AKI staging based on AKIN criteria.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="10%" span="1"/><col width="45%" span="1"/><col width="45%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Stage</th><th align="center" rowspan="1" colspan="1">Serum creatinine criteria</th><th align="center" rowspan="1" colspan="1">Urine output criteria</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Stage 1</td><td align="left" rowspan="1" colspan="1">Increase in SCr by &#x02265; 0.3 mg/dL or &#x02265;
1.5&#x02264; 2.0 times baseline</td><td align="left" rowspan="1" colspan="1">Less than 0.5 mL/kg per hour for more than 6 hours</td></tr><tr><td align="left" rowspan="1" colspan="1">Stage 2</td><td align="left" rowspan="1" colspan="1">Increase in SCr by &#x02265; 2.0&#x02264; 3.0 times
baseline</td><td align="left" rowspan="1" colspan="1">Less than 0.5 mL/kg per hour for more than 12
hours</td></tr><tr><td align="left" rowspan="1" colspan="1">Stage 3</td><td align="left" rowspan="1" colspan="1">Increase in SCr by &#x02265; 3.0 times baseline or SCr
&#x0003e; 4 mg/dL</td><td align="left" rowspan="1" colspan="1">Less than 0.3 mL/kg per hour for 24 hours or anuria for
12 hours</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>AKI=Acute kidney injury; AKIN=Acute Kidney Injury Network; SCr=serum
creatinine</p></fn></table-wrap-foot></table-wrap><p>The estimated glomerular filtration rate (eGFR) was calculated with the
Cockroft-Gault equation assuming kidney function in
steady-state<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>. Duration (recovery) of AKI was defined as return
of creatinine or glomerular filtration rate to baseline. Patients underwent RRT in
case of refractory acid-base and electrolyte disorders, signs of hypervolemia or
loss of consciousness attributable to hyperuremia.</p><p>Patients were discharged from ICU if they were conscious, hemodynamically stable with
acceptable oxygenation and ventilation (PaO<sub>2</sub>/FiO<sub>2</sub> &#x0003e; 200,
PaCO<sub>2</sub>=35-50 mmHg), no life-threatening arrhythmias, no active
bleeding, electrolyte disorders, delirium, severe anemia (Hb &#x0003c; 8 g/dL), and after
removal of the pericardial drain.</p><p>The study was registered at Iran Registry of Clinical Trials under number
IRCT2015021621098N1.</p><sec><title>Statistical Analysis</title><p>The sample size was calculated based on the study of Adabag et
al.<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup> as 64 cases in each group. The sample size was
increased to 292 to compensate a missing of 10%-15%.</p><p>Statistical analysis was performed using SPSS<sup>&#x000ae;</sup> version 16 (IBM
SPSS, Chicago, IL, USA). Means and standard deviation were used for normal
distribution variables and median and interquartile range for otherwise.
Frequencies and percentages were used for categorical variables. The ANOVA test
was used to compare variables among groups. Chi-square test or Fisher's exact
test was used for categorical variables. Statistical significance was considered
as <italic>P</italic>&#x0003c;0.05.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>Two hundred and seventy-two patients completed the study with a mean age of
59.35&#x000b1;9.88 (ranging from 29 to 83) years. Of these, there were 180 males and
92 females. Two patients in the vitamin C and NAC groups were excluded for excessive
bleeding and receiving more than 2 units of RBCs. One patient in the selenium group
received NAC for respiratory problems. Five patients were excluded due to changing
off-pump to on-pump technique intraoperatively. Eight patients received IABP
intraoperatively because of hemodynamic compromise. Finally, three patients
underwent on-pump CABG and received IABP simultaneously (<xref ref-type="fig" rid="f1">Figure 1</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Patients' randomization, initial and final participants.</p></caption><graphic xlink:href="rbccv-33-02-0129-g01"/></fig>
</p><p>Patients were similar in relation to demographic data, comorbidities, European System
for Cardiac Operative Risk Evaluation (EuroSCORE) II, cardiovascular status,
baseline creatinine and eGFR (<xref ref-type="table" rid="t2">Table 2</xref>). There
were no significant differences among the patients regarding the duration of surgery
(4.05&#x000b1;0.79, 4.35&#x000b1;0.84, 4.17&#x000b1;0.82, 4.21&#x000b1;0.95 hours;
<italic>P</italic>=0.225), number of grafts (3.29&#x000b1;0.51, 3.19&#x000b1;0.71,
3.25&#x000b1;0.76, and 3.08&#x000b1;0.69; <italic>P</italic>=0.314), units of RBC
transfusion (0.68&#x000b1;0.66, 0.84&#x000b1;0.58, 0.78&#x000b1;0.71, and
0.58&#x000b1;0.71; <italic>P</italic>=0.114) and administered colloids
(161.54&#x000b1;307.55, 224.26&#x000b1;296.55, 208.96&#x000b1;277.28, and
169.01&#x000b1;315.59; <italic>P</italic>=0.555) in the selenium, NAC, vitamin C, and
control groups, respectively.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Demographic data and clinical characteristics.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Selenium&#x000a0;</th><th align="center" rowspan="1" colspan="1">NAC</th><th align="center" rowspan="1" colspan="1">Vitamin C&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;</th><th align="center" rowspan="1" colspan="1">Control</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;</td><td align="center" rowspan="1" colspan="1">58.21&#x000b1;10.54</td><td align="center" rowspan="1" colspan="1">60.03&#x000b1;10.37</td><td align="center" rowspan="1" colspan="1">60.46&#x000b1;10.03</td><td align="center" rowspan="1" colspan="1">58.72&#x000b1;8.57</td><td align="center" rowspan="1" colspan="1">0.508</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex (male:female)&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;</td><td align="center" rowspan="1" colspan="1">52:14:00</td><td align="center" rowspan="1" colspan="1">41:27:00</td><td align="center" rowspan="1" colspan="1">38:29:00</td><td align="center" rowspan="1" colspan="1">49:22:00</td><td align="center" rowspan="1" colspan="1">0.034</td></tr><tr><td align="left" rowspan="1" colspan="1">Weight (kg)</td><td align="center" rowspan="1" colspan="1">74.93&#x000b1;14.01</td><td align="center" rowspan="1" colspan="1">75.06&#x000b1;18.95</td><td align="center" rowspan="1" colspan="1">71.28&#x000b1;13.56</td><td align="center" rowspan="1" colspan="1">72.56&#x000b1;12.48</td><td align="center" rowspan="1" colspan="1">0.378</td></tr><tr><td align="left" rowspan="1" colspan="1">Height (cm)&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;</td><td align="center" rowspan="1" colspan="1">166.77&#x000b1;9.03</td><td align="center" rowspan="1" colspan="1">164.07&#x000b1;10.27</td><td align="center" rowspan="1" colspan="1">164.48&#x000b1;9.48</td><td align="center" rowspan="1" colspan="1">165.4&#x000b1;10.12</td><td align="center" rowspan="1" colspan="1">0.418</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass index</td><td align="center" rowspan="1" colspan="1">26.92&#x000b1;4.62</td><td align="center" rowspan="1" colspan="1">27.82&#x000b1;5.91</td><td align="center" rowspan="1" colspan="1">26.14&#x000b1;3.45</td><td align="center" rowspan="1" colspan="1">26.54&#x000b1;4.31</td><td align="center" rowspan="1" colspan="1">0.190</td></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial infarction</td><td align="center" rowspan="1" colspan="1">6 (9.09)</td><td align="center" rowspan="1" colspan="1">2 (2.94)</td><td align="center" rowspan="1" colspan="1">4 (5.97)</td><td align="center" rowspan="1" colspan="1">3 (4.22)</td><td align="center" rowspan="1" colspan="1">0.439</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">24 (36.36)</td><td align="center" rowspan="1" colspan="1">30 (44.11)</td><td align="center" rowspan="1" colspan="1">27 (40.29)</td><td align="center" rowspan="1" colspan="1">27 (38.02)</td><td align="center" rowspan="1" colspan="1">0.885</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes</td><td align="center" rowspan="1" colspan="1">26 (39.39)</td><td align="center" rowspan="1" colspan="1">22 (32.35)</td><td align="center" rowspan="1" colspan="1">31 (46.26)</td><td align="center" rowspan="1" colspan="1">20 (28.16)</td><td align="center" rowspan="1" colspan="1">0.228</td></tr><tr><td align="left" rowspan="1" colspan="1">Hyperlipidemia</td><td align="center" rowspan="1" colspan="1">19 (28.78)</td><td align="center" rowspan="1" colspan="1">19 (27.94)</td><td align="center" rowspan="1" colspan="1">17 (25.37)</td><td align="center" rowspan="1" colspan="1">24 (33.80)</td><td align="center" rowspan="1" colspan="1">0.464</td></tr><tr><td align="left" rowspan="1" colspan="1">Ejection fraction</td><td align="center" rowspan="1" colspan="1">53.17&#x000b1;7.06</td><td align="center" rowspan="1" colspan="1">50.09&#x000b1;8.09</td><td align="center" rowspan="1" colspan="1">51.7&#x000b1;7.44</td><td align="center" rowspan="1" colspan="1">50.58&#x000b1;6.42</td><td align="center" rowspan="1" colspan="1">0.710</td></tr><tr><td align="left" rowspan="1" colspan="1">NYHA (I or II/III)</td><td align="center" rowspan="1" colspan="1">39/27</td><td align="center" rowspan="1" colspan="1">48/20</td><td align="center" rowspan="1" colspan="1">37/30</td><td align="center" rowspan="1" colspan="1">48/25</td><td align="center" rowspan="1" colspan="1">0.403</td></tr><tr><td align="left" rowspan="1" colspan="1">Left main/3 vessel disease</td><td align="center" rowspan="1" colspan="1">10 (15.2)</td><td align="center" rowspan="1" colspan="1">10 (14.7)</td><td align="center" rowspan="1" colspan="1">7 (10.4)</td><td align="center" rowspan="1" colspan="1">10 (14.1)</td><td align="center" rowspan="1" colspan="1">0.853</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking</td><td align="center" rowspan="1" colspan="1">10 (15.15)</td><td align="center" rowspan="1" colspan="1">11 (16.17)</td><td align="center" rowspan="1" colspan="1">5 (7.46)</td><td align="center" rowspan="1" colspan="1">8 (11.27)</td><td align="center" rowspan="1" colspan="1">0.416</td></tr><tr><td align="left" rowspan="1" colspan="1">Drug abuse</td><td align="center" rowspan="1" colspan="1">18 (27.27)</td><td align="center" rowspan="1" colspan="1">16 (23.52)</td><td align="center" rowspan="1" colspan="1">11 (16.41)</td><td align="center" rowspan="1" colspan="1">18 (25.35)</td><td align="center" rowspan="1" colspan="1">0.342</td></tr><tr><td align="left" rowspan="1" colspan="1">EuroSCORE</td><td align="center" rowspan="1" colspan="1">1.34&#x000b1;0.765</td><td align="center" rowspan="1" colspan="1">1.50&#x000b1;0.786</td><td align="center" rowspan="1" colspan="1">1.56&#x000b1;0.970</td><td align="center" rowspan="1" colspan="1">1.29&#x000b1;0.620</td><td align="center" rowspan="1" colspan="1">0.167</td></tr><tr><td align="left" rowspan="1" colspan="1">Baseline Cr</td><td align="center" rowspan="1" colspan="1">0.983&#x000b1;0.18</td><td align="center" rowspan="1" colspan="1">0.95&#x000b1;0.19</td><td align="center" rowspan="1" colspan="1">0.96&#x000b1;0.16</td><td align="center" rowspan="1" colspan="1">0.98&#x000b1;0.18</td><td align="center" rowspan="1" colspan="1">0.757</td></tr><tr><td align="left" rowspan="1" colspan="1">Baseline GFR</td><td align="center" rowspan="1" colspan="1">86.32&#x000b1;25.28</td><td align="center" rowspan="1" colspan="1">87.46&#x000b1;41.31</td><td align="center" rowspan="1" colspan="1">79.26&#x000b1;24.21</td><td align="center" rowspan="1" colspan="1">87.02&#x000b1;21.29&#x000a0;&#x000a0;&#x000a0;</td><td align="center" rowspan="1" colspan="1">0.330</td></tr><tr><td align="left" rowspan="1" colspan="1">Date of angiography</td><td align="center" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0; 25.22&#x000b1;29.04&#x000a0;</td><td align="center" rowspan="1" colspan="1">28.25&#x000b1;46.18</td><td align="center" rowspan="1" colspan="1">31.13&#x000b1;43.58</td><td align="center" rowspan="1" colspan="1">24.05&#x000b1;21.31</td><td align="center" rowspan="1" colspan="1">0.775</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>Data are presented as mean &#x000b1; standard deviation or numbers
(percentage).</p><p>Cr=creatinine; GFR=glomerular filtration rate; NAC=N-acetylcysteine;
NYHA=New York Heart Association</p></fn></table-wrap-foot></table-wrap><p>Based on AKIN criteria, AKI was seen in 60 (22.1%) patients with no significant
difference in incidence, severity, duration, and day of occurrence of AKI among the
four groups (<xref ref-type="table" rid="t3">Table 3</xref>).</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Frequency and characteristics of AKI based on AKIN criteria.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Selenium</th><th align="center" rowspan="1" colspan="1">NAC</th><th align="center" rowspan="1" colspan="1">Vitamin C</th><th align="center" rowspan="1" colspan="1">Control</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Frequency of AKI</td><td align="center" rowspan="1" colspan="1">21 (31.8)</td><td align="center" rowspan="1" colspan="1">15 (22.1)</td><td align="center" rowspan="1" colspan="1">14 (20.9)</td><td align="center" rowspan="1" colspan="1">10 (14.1)</td><td align="center" rowspan="1" colspan="1">0.096</td></tr><tr><td align="left" rowspan="1" colspan="1">Stage I</td><td align="center" rowspan="1" colspan="1">19 (31.7)</td><td align="center" rowspan="1" colspan="1">13 (21.7)</td><td align="center" rowspan="1" colspan="1">13 (21.7)</td><td align="center" rowspan="1" colspan="1">6 (10)</td><td align="center" rowspan="1" colspan="1">0.020</td></tr><tr><td align="left" rowspan="1" colspan="1">Stage</td><td align="center" rowspan="1" colspan="1">1 (1.7)</td><td align="center" rowspan="1" colspan="1">2 (3.3)</td><td align="center" rowspan="1" colspan="1">1 (1.7)</td><td align="center" rowspan="1" colspan="1">3 (5)</td><td align="center" rowspan="1" colspan="1">0.700</td></tr><tr><td align="left" rowspan="1" colspan="1">Stage III</td><td align="center" rowspan="1" colspan="1">1 (1.7)</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">1 (1.7)</td><td align="center" rowspan="1" colspan="1">0.570</td></tr><tr><td align="left" rowspan="1" colspan="1">Day of occurrence</td><td align="center" rowspan="1" colspan="1">3.05&#x000b1;1.62&#x000a0;</td><td align="center" rowspan="1" colspan="1">2.80&#x000b1;1.37</td><td align="center" rowspan="1" colspan="1">2.57&#x000b1;1.60</td><td align="center" rowspan="1" colspan="1">3.40&#x000b1;1.64</td><td align="center" rowspan="1" colspan="1">0.677</td></tr><tr><td align="left" rowspan="1" colspan="1">Day of maximum severity</td><td align="center" rowspan="1" colspan="1">3.24&#x000b1;1.57</td><td align="center" rowspan="1" colspan="1">3.20&#x000b1;1.52</td><td align="center" rowspan="1" colspan="1">2.57&#x000b1;1.60</td><td align="center" rowspan="1" colspan="1">3.60&#x000b1;1.57</td><td align="center" rowspan="1" colspan="1">0.558</td></tr><tr><td align="left" rowspan="1" colspan="1">Frequency of recovery</td><td align="center" rowspan="1" colspan="1">16 (26.7)</td><td align="center" rowspan="1" colspan="1">9 (15)</td><td align="center" rowspan="1" colspan="1">13 (21.7)</td><td align="center" rowspan="1" colspan="1">7 (11.7)</td><td align="center" rowspan="1" colspan="1">0.228</td></tr><tr><td align="left" rowspan="1" colspan="1">Duration of AKI</td><td align="center" rowspan="1" colspan="1">1.86&#x000b1;0.81&#x000a0;&#x000a0;</td><td align="center" rowspan="1" colspan="1">1.78&#x000b1;0.97</td><td align="center" rowspan="1" colspan="1">1.23&#x000b1;0.43</td><td align="center" rowspan="1" colspan="1">4.29&#x000b1;8.26</td><td align="center" rowspan="1" colspan="1">0.465</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>Data are presented as mean &#x000b1; standard deviation or numbers
(percentage).</p><p>AKI=Acute kidney injury; AKIN=Acute Kidney Injury Network;
NAC=N-acetylcysteine</p></fn></table-wrap-foot></table-wrap><p>The mean overall duration of mechanical ventilation was 12.53&#x000b1;81.62 hours,
with median of 5 hours. Ventilation times were 7.33&#x000b1;6.02, 10.68&#x000b1;27.15,
5.90&#x000b1;3.13, and 25.36&#x000b1;157.5 hours in the vitamin C, NAC, selenium and
control groups, respectively (<italic>P</italic>=0.429). The mean overall ICU LOS
was 2.66&#x000b1;3.87 days with a median of 2 days. The ICU LOS in the vitamin C,
NAC, selenium and control groups was 2.36&#x000b1;0.86, 2.57&#x000b1;1.50,
2.30&#x000b1;0.78, and 3.20&#x000b1;7.36 days, respectively
(<italic>P</italic>=0.207).</p><p>The overall mean hospital LOS was 6.45&#x000b1;4.17 days with a median of 6 days. Mean
hospital LOS were 6.06&#x000b1;1.32, 6.57&#x000b1;2.70, 6.11&#x000b1;1.43, and
7.01&#x000b1;7.50 days in the vitamin C, NAC, selenium and control groups,
respectively (<italic>P</italic>=0.970).</p><p>In-hospital mortality occurred in 4 (1.47%) patients, including 2 (3%), 1 (1.5%), 1
(1.5%), and zero cases in the vitamin C, NAC, selenium and control groups,
respectively (<italic>P</italic>=0.548).</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Our study revealed that perioperative use of vitamin C, NAC, or selenium did not
affect the occurrence of AKI and associated mortality and morbidity after off-pump
CABG.</p><p>The protective effect of selenium for AKI has been proposed for its antioxidant
effects<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>. Shanu et al.<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup> proposed that selenium could have
therapeutic effects in AKI after rhabdomyolysis in the animal model. However, their
findings were inconclusive. We did not find any protective effects in our study. As
far as we know, there is no studies exploring the efficacy of selenium in prevention
of AKI following cardiac surgery in humans.</p><p>Although we used NAC in off-pump low-risk patients, our results are consistent with
other reports that suggested NAC was not effective in reducing AKI in high-risk
patients undergoing on-pump<sup>[<xref rid="r23" ref-type="bibr">23</xref>-<xref rid="r25" ref-type="bibr">25</xref>]</sup> and off- pump CABG<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup>. In contrast, a
meta-analysis investigating the impact of NAC, vitamin C and polyunsaturated fatty
acids (PUFA) on prevention of AKI after cardiac surgery revealed that only NAC was
effective<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup>. Furthermore, in a recent study, Savluk et
al.<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup>
reported that the prophylactic use of intravenous NAC had a protective effect on
renal function in patients undergoing CABG using cardiopulmonary bypass (CPB) with
pre-existing moderate renal failure. Use of CPB and pre-existing renal insufficiency
might explain this difference and NAC may be effective in especial group of patients
undergoing cardiac surgery.</p><p>The administration of vitamin C in the prevention of contrast-induced nephropathy
(CIN) after coronary angiography has been associated with different
results<sup>[<xref rid="r29" ref-type="bibr">29</xref>,<xref rid="r30" ref-type="bibr">30</xref>]</sup>. We could not show any benefit of vitamin C in
reducing the incidence of AKI. Nephrotoxicity in CIN <italic>versus</italic>
hypoperfusion in CABG as proposed mechanisms for the development of AKI can explain
the difference.</p><p>None of our patients required RRT during hospitalization. This can be attributed to
the inclusion of low-risk patients, low-risk surgery, and low severity of AKI in our
patients.</p><p>Our study had a few limitations as well. First, we used oral forms of the drugs with
different bioavailability from parenteral forms because of high cost and resource
limitations in our institution. Second, our patients were at low risk for AKI and
underwent CABG without CPB. Therefore, our results cannot be extrapolated to
high-risk patients or those undergoing on-pump CABG. Third, we did not use urine
output for diagnosis of AKI that might lose some cases according to the existing
definitions. Forth, we did not measure hemoglobin A1C to differentiate poor from
well-controlled diabetes in both diabetics and non-diabetics that can affect the
development of AKI as reported by Kocogullar&#x00131; et al.<sup>[<xref rid="r31" ref-type="bibr">31</xref>]</sup>, suggesting an
association between preoperative level of Hb A<sub>1C</sub> and development of AKI
in non-diabetics.</p><p>In conclusion, we found that perioperative administration of NAC, vitamin C or
selenium could not reduce the incidence of AKI and its associated mortality and
morbidity in patients undergoing off-pump CABG.</p><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">SA</td><td align="left" rowspan="1" colspan="1">Conception and study design; analysis and/or data
interpretation; manuscript redaction or critical review of its
content; final manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">HNR</td><td align="left" rowspan="1" colspan="1">Conception and study design; analysis and/or data
interpretation; manuscript redaction or critical review of its
content; final manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">MAT</td><td align="left" rowspan="1" colspan="1">Analysis and/or data interpretation; manuscript
redaction or critical review of its content; final manuscript
approval</td></tr><tr><td align="left" rowspan="1" colspan="1">VV</td><td align="left" rowspan="1" colspan="1">Statistical analysis; manuscript redaction or critical
review of its content; final manuscript approval</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out Mashhad University of Medical Sciences, Mashhad,
Iran.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><fn-group><fn fn-type="financial-disclosure"><p>No financial support</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ack><title>ACKNOWLEDGEMENT </title><p>We would like to thank the ICU nursing staff of post-cardiac surgery at Emam Reza
Hospital, Mashhad, Iran, for their contribution to this study.</p></ack><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>H</given-names></name><name><surname>Katz</surname><given-names>N</given-names></name><name><surname>Ariyanon</surname><given-names>W</given-names></name><name><surname>Blanca-Martos</surname><given-names>L</given-names></name><name><surname>Ad&#x000fd;belli</surname><given-names>Z</given-names></name><name><surname>Giuliani</surname><given-names>A</given-names></name><etal/></person-group><article-title>Cardiac surgery-associated acute kidney injury</article-title><source>Cardiorenal Med</source><year>2013</year><volume>3</volume><issue>3</issue><fpage>178</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">24454314</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoste</surname><given-names>EA</given-names></name><name><surname>Cruz</surname><given-names>DN</given-names></name><name><surname>Davenport</surname><given-names>A</given-names></name><name><surname>Mehta</surname><given-names>R</given-names></name><name><surname>Piccinni</surname><given-names>P</given-names></name><name><surname>Tetta</surname><given-names>C</given-names></name><etal/></person-group><article-title>The epidemiology of cardiac surgery-associated acute kidney
injury</article-title><source>Int J Artif Organs</source><year>2008</year><volume>31</volume><issue>2</issue><fpage>158</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">18311732</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lassnigg</surname><given-names>A</given-names></name><name><surname>Schmidlin</surname><given-names>D</given-names></name><name><surname>Mouhieddine</surname><given-names>M</given-names></name><name><surname>Bachmann</surname><given-names>LM</given-names></name><name><surname>Druml</surname><given-names>W</given-names></name><name><surname>Bauer</surname><given-names>P</given-names></name><etal/></person-group><article-title>Minimal changes of serum creatinine predict prognosis in patients
after cardiothoracic surgery: a prospective cohort study</article-title><source>J Am Soc Nephrol</source><year>2004</year><volume>15</volume><issue>6</issue><fpage>1597</fpage><lpage>1605</lpage><pub-id pub-id-type="pmid">15153571</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>RH</given-names></name><name><surname>Grab</surname><given-names>JD</given-names></name><name><surname>O'Brien</surname><given-names>SM</given-names></name><name><surname>Bridges</surname><given-names>CR</given-names></name><name><surname>Gammie</surname><given-names>JS</given-names></name><name><surname>Haan</surname><given-names>CK</given-names></name><etal/><collab>Society of Thoracic Surgeons National Cardiac Surgery Database
Investigators</collab></person-group><article-title>Bedside tool for predicting the risk of postoperative dialysis in
patients undergoing cardiac surgery</article-title><source>Circulation</source><year>2006</year><volume>114</volume><issue>21</issue><fpage>2208</fpage><lpage>2216</lpage><pub-id pub-id-type="pmid">17088458</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thakar</surname><given-names>CV</given-names></name><name><surname>Arrigain</surname><given-names>S</given-names></name><name><surname>Worley</surname><given-names>S</given-names></name><name><surname>Yared</surname><given-names>JP</given-names></name><name><surname>Paganini</surname><given-names>EP</given-names></name></person-group><article-title>A clinical score to predict acute renal failure after cardiac
surgery</article-title><source>J Am Soc Nephrol</source><year>2005</year><volume>16</volume><issue>1</issue><fpage>162</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">15563569</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wijeysundera</surname><given-names>DN</given-names></name><name><surname>Karkouti</surname><given-names>K</given-names></name><name><surname>Dupuis</surname><given-names>JY</given-names></name><name><surname>Rao</surname><given-names>V</given-names></name><name><surname>Chan</surname><given-names>CT</given-names></name><name><surname>Granton</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Derivation and validation of a simplified predictive index for
renal replacement therapy after cardiac surgery</article-title><source>JAMA</source><year>2007</year><volume>297</volume><issue>16</issue><fpage>1801</fpage><lpage>1809</lpage><pub-id pub-id-type="pmid">17456822</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lameire</surname><given-names>N</given-names></name><name><surname>van Biesen</surname><given-names>W</given-names></name><name><surname>Hoste</surname><given-names>E</given-names></name><name><surname>Vanholder</surname><given-names>R</given-names></name></person-group><article-title>The prevention of acute kidney injury an in-depth narrative
review Part 2: Drugs in the prevention of acute kidney
injury</article-title><source>NDT Plus</source><year>2009</year><volume>2</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">25949275</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonucci</surname><given-names>F</given-names></name><name><surname>Calo</surname><given-names>L</given-names></name><name><surname>Rizzolo</surname><given-names>M</given-names></name><name><surname>Cantaro</surname><given-names>S</given-names></name><name><surname>Bertolossi</surname><given-names>M</given-names></name><name><surname>Travaglini</surname><given-names>M</given-names></name><etal/></person-group><article-title>Nifedipine can preserve renal function in patients undergoing
aortic surgery with infrarenal crossclamping</article-title><source>Nephron</source><year>1996</year><volume>74</volume><issue>4</issue><fpage>668</fpage><lpage>673</lpage><pub-id pub-id-type="pmid">8956299</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergman</surname><given-names>AS</given-names></name><name><surname>Odar-Cederl&#x000f6;f</surname><given-names>I</given-names></name><name><surname>Westman</surname><given-names>L</given-names></name></person-group><article-title>Renal and hemodynamic effects of diltiazem after elective major
vascular surgery: a potential renoprotective agent?</article-title><source>Renal Fail</source><year>1995</year><volume>17</volume><issue>2</issue><fpage>155</fpage><lpage>163</lpage></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colson</surname><given-names>P</given-names></name><name><surname>Ribstein</surname><given-names>J</given-names></name><name><surname>S&#x000e9;guin</surname><given-names>JR</given-names></name><name><surname>Marty-Ane</surname><given-names>C</given-names></name><name><surname>Roquefeuil</surname><given-names>B</given-names></name></person-group><article-title>Mechanisms of renal hemodynamic impairment during infrarenal
aortic cross-clamping</article-title><source>Anesth Analg</source><year>1992</year><volume>75</volume><issue>1</issue><fpage>18</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">1616156</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billings</surname><given-names>FT 4th</given-names></name><name><surname>Pretorius</surname><given-names>M</given-names></name><name><surname>Siew</surname><given-names>ED</given-names></name><name><surname>You</surname><given-names>C</given-names></name><name><surname>Brown</surname><given-names>NJ</given-names></name></person-group><article-title>Early postoperative statin therapy is associated with a lower
incidence of acute kidney injury after cardiac surgery</article-title><source>J Cardiothoracic Vasc Anesth</source><year>2010</year><volume>24</volume><issue>6</issue><fpage>913</fpage><lpage>920</lpage></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liakopoulos</surname><given-names>OJ</given-names></name><name><surname>Choi</surname><given-names>YH</given-names></name><name><surname>Kuhn</surname><given-names>EW</given-names></name><name><surname>Wittwer</surname><given-names>T</given-names></name><name><surname>Borys</surname><given-names>M</given-names></name><name><surname>Madershahian</surname><given-names>N</given-names></name><etal/></person-group><article-title>Statins for prevention of atrial fibrillation after cardiac
surgery: a systematic literature review</article-title><source>J Thorac Cardiovasc Surg</source><year>2009</year><volume>138</volume><issue>3</issue><fpage>678</fpage><lpage>686</lpage><pub-id pub-id-type="pmid">19698856</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ratliff</surname><given-names>BB</given-names></name><name><surname>Abdulmahdi</surname><given-names>W</given-names></name><name><surname>Pawar</surname><given-names>R</given-names></name><name><surname>Wolin</surname><given-names>MS</given-names></name></person-group><article-title>Oxidant mechanisms in renal injury and disease</article-title><source>Antioxid Redox Signal</source><year>2016</year><volume>25</volume><issue>3</issue><fpage>119</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">26906267</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karwasra</surname><given-names>R</given-names></name><name><surname>Kalra</surname><given-names>P</given-names></name><name><surname>Gupta</surname><given-names>YK</given-names></name><name><surname>Saini</surname><given-names>D</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name></person-group><article-title>Antioxidant and anti-inflammatory potential of pomegranate rind
extract to ameliorate cisplatin-induced acute kidney injury</article-title><source>Food Funct</source><year>2016</year><volume>7</volume><issue>7</issue><fpage>3091</fpage><lpage>3101</lpage><pub-id pub-id-type="pmid">27273121</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konda</surname><given-names>VG</given-names></name><name><surname>Eerike</surname><given-names>M</given-names></name><name><surname>Raghuraman</surname><given-names>LP</given-names></name><name><surname>Rajamanickam</surname><given-names>MK</given-names></name></person-group><article-title>Antioxidant and nephroprotective activities of aconitum
heterophyllum root in glycerol induced acute renal failure in
rats</article-title><source>J Clin Diagn Res</source><year>2016</year><volume>10</volume><issue>3</issue><fpage>FF01</fpage><lpage>FF02</lpage></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name></person-group><article-title>Attenuation of renal ischemia/reperfusion injury by oleanolic
acid preconditioning via its antioxidant, anti-inflammatory, and
anti-apoptotic activities</article-title><source>Mol Med Rep</source><year>2016</year><volume>13</volume><issue>6</issue><fpage>4697</fpage><lpage>4704</lpage><pub-id pub-id-type="pmid">27082705</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mahmoudzadeh</surname><given-names>L</given-names></name><name><surname>Najafi</surname><given-names>H</given-names></name><name><surname>Ashtiyani</surname><given-names>SC</given-names></name><name><surname>Yarijani</surname><given-names>ZM</given-names></name></person-group><article-title>Anti-inflammatory and protective effects of saffron extract in
ischaemia-reperfusion-induced acute kidney injury</article-title><source>Nephrology</source><publisher-loc>Carlton</publisher-loc><year>2017</year><volume>22</volume><issue>10</issue><fpage>748</fpage><lpage>754</lpage><pub-id pub-id-type="pmid">27381453</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezaei</surname><given-names>Y</given-names></name><name><surname>Khademvatani</surname><given-names>K</given-names></name><name><surname>Rahimi</surname><given-names>B</given-names></name><name><surname>Khoshfetrat</surname><given-names>M</given-names></name><name><surname>Arjmand</surname><given-names>N</given-names></name><name><surname>Seyyed-Mohammadzad</surname><given-names>MH</given-names></name></person-group><article-title>Short-term high-dose vitamin E to prevent contrast medium-induced
acute kidney injury in patients with chronic kidney disease undergoing
elective coronary angiography: a randomized placebo-controlled
trial</article-title><source>J Am Heart Assoc</source><year>2016</year><volume>15</volume><issue>3</issue><elocation-id>e002919</elocation-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joannidis</surname><given-names>M</given-names></name></person-group><article-title>Medical therapy of acute kidney injury</article-title><source>Acta Clinic Belg</source><year>2007</year><volume>62</volume><issue>Suppl 2</issue><fpage>353</fpage><lpage>356</lpage></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shanu</surname><given-names>A</given-names></name><name><surname>Groebler</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>HB</given-names></name><name><surname>Wood</surname><given-names>S</given-names></name><name><surname>Weekley</surname><given-names>CM</given-names></name><name><surname>Aitken</surname><given-names>JB</given-names></name><etal/></person-group><article-title>Selenium inhibits renal oxidation and inflammation but not acute
kidney injury in an animal model of rhabdomyolysis</article-title><source>Antioxid Redox Signal</source><year>2013</year><volume>18</volume><issue>7</issue><fpage>756</fpage><lpage>769</lpage><pub-id pub-id-type="pmid">22937747</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sisillo</surname><given-names>E</given-names></name><name><surname>Ceriani</surname><given-names>R</given-names></name><name><surname>Bortone</surname><given-names>F</given-names></name><name><surname>Juliano</surname><given-names>G</given-names></name><name><surname>Salvi</surname><given-names>L</given-names></name><name><surname>Veglia</surname><given-names>F</given-names></name><etal/></person-group><article-title>N-acetylcysteine for prevention of acute renal failure in
patients with chronic renal insufficiency undergoing cardiac surgery: a
prospective, randomized, clinical trial</article-title><source>Crit Care Med</source><year>2008</year><volume>36</volume><issue>1</issue><fpage>81</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">18090169</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cockroft</surname><given-names>DW</given-names></name><name><surname>Gault</surname><given-names>MH</given-names></name></person-group><article-title>Prediction of creatinine clearance from serum
creatinine</article-title><source>Nephron</source><year>1976</year><volume>16</volume><issue>1</issue><fpage>31</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">1244564</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adabag</surname><given-names>AS</given-names></name><name><surname>Ishani</surname><given-names>A</given-names></name><name><surname>Koneswaran</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>DJ</given-names></name><name><surname>Kelly</surname><given-names>RF</given-names></name><name><surname>Ward</surname><given-names>HB</given-names></name><etal/></person-group><article-title>Utility of N-acetylcysteine to prevent acute kidney injury after
cardiac surgery: a randomized controlled trial</article-title><source>Am Heart J</source><year>2008</year><volume>155</volume><issue>6</issue><fpage>1143</fpage><lpage>1149</lpage><pub-id pub-id-type="pmid">18513531</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burns</surname><given-names>KE</given-names></name><name><surname>Chu</surname><given-names>MW</given-names></name><name><surname>Novick</surname><given-names>RJ</given-names></name><name><surname>Fox</surname><given-names>SA</given-names></name><name><surname>Gallo</surname><given-names>K</given-names></name><name><surname>Martin</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Perioperative N-acetylcysteine to prevent renal dysfunction in
high-risk patients undergoing CAGB surgery: a randomized controlled
trial</article-title><source>JAMA</source><year>2005</year><volume>294</volume><issue>3</issue><fpage>342</fpage><lpage>350</lpage><pub-id pub-id-type="pmid">16030279</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haase</surname><given-names>M</given-names></name><name><surname>Hasse-Fielitz</surname><given-names>A</given-names></name><name><surname>Bagshaw</surname><given-names>SM</given-names></name><name><surname>Reade</surname><given-names>MC</given-names></name><name><surname>Morgera</surname><given-names>S</given-names></name><name><surname>Seevanayagam</surname><given-names>S</given-names></name><etal/></person-group><article-title>Phase II, randomized, controlled trial of high-dose
N-acetylcysteine in high-risk cardiac surgery patients</article-title><source>Crit Care Med</source><year>2007</year><volume>35</volume><issue>5</issue><fpage>1324</fpage><lpage>1331</lpage><pub-id pub-id-type="pmid">17414730</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Song</surname><given-names>JW</given-names></name><name><surname>Shim</surname><given-names>JK</given-names></name><name><surname>Soh</surname><given-names>S</given-names></name><name><surname>Jang</surname><given-names>J</given-names></name><name><surname>Kwak</surname><given-names>YL</given-names></name></person-group><article-title>Double-blinded, randomized controlled trial of N-acetylcysteine
for prevention of acute kidney injury in high ris patients undergoing
off-pump coronary artery bypass</article-title><source>Nephrology</source><publisher-name>Carlton</publisher-name><year>2015</year><volume>20</volume><issue>2</issue><fpage>96</fpage><lpage>102</lpage></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali-Hassan-Sayegh</surname><given-names>S</given-names></name><name><surname>Mirhosseini</surname><given-names>SJ</given-names></name><name><surname>Tahernejad</surname><given-names>M</given-names></name><name><surname>Mahdavi</surname><given-names>P</given-names></name><name><surname>Shahidzadeh</surname><given-names>A</given-names></name><name><surname>Karimi-Bondarabadi</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Impact of antioxidant supplementations of cardio-renal protection
in cardiac surgery: an updated and comprehensive meta-analysis and
systematic review</article-title><source>Cardiovasc Ther</source><year>2016</year><volume>34</volume><issue>5</issue><fpage>360</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">27344977</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savluk</surname><given-names>OF</given-names></name><name><surname>Guzelmeric</surname><given-names>F</given-names></name><name><surname>Yavuz</surname><given-names>Y</given-names></name><name><surname>Cevirme</surname><given-names>D</given-names></name><name><surname>Gurcu</surname><given-names>E</given-names></name><name><surname>Ogus</surname><given-names>H</given-names></name><etal/></person-group><article-title>N-acetylcysteine versus dopamine to prevent acute kidney injury
after cardiac surgery in patients with preexisting moderate renal
insufficiency</article-title><source>Braz J Cardiovasc Surg</source><year>2017</year><volume>32</volume><issue>1</issue><fpage>8</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">28423123</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spargias</surname><given-names>K</given-names></name><name><surname>Alexopoulos</surname><given-names>E</given-names></name><name><surname>Kyrzopoulos</surname><given-names>S</given-names></name><name><surname>Iokovis</surname><given-names>P</given-names></name><name><surname>Greenwood</surname><given-names>DC</given-names></name><name><surname>Manginas</surname><given-names>A</given-names></name><etal/></person-group><article-title>Ascorbic acid prevents contrast-mediated nephropathy in patients
with renal dysfunction undergoing coronary angiography or
intervention</article-title><source>Circulation</source><year>2004</year><volume>110</volume><issue>18</issue><fpage>2837</fpage><lpage>2842</lpage><pub-id pub-id-type="pmid">15492300</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name></person-group><article-title>Prevention of contrast-induced nephropathy with ascorbic
acid</article-title><source>Intern Med</source><year>2012</year><volume>51</volume><issue>6</issue><fpage>531</fpage><lpage>535</lpage><pub-id pub-id-type="pmid">22449658</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kocogullari</surname><given-names>CU</given-names></name><name><surname>Kunt</surname><given-names>AT</given-names></name><name><surname>Aksoy</surname><given-names>R</given-names></name><name><surname>Duzyol</surname><given-names>C</given-names></name><name><surname>Parlar</surname><given-names>H</given-names></name><name><surname>Saskin</surname><given-names>H</given-names></name><etal/></person-group><article-title>Hemoglobin A1c levels predicts acute kidney injury after coronary
artery bypass surgery in non-diabetic patients</article-title><source>Braz J Cardiovasc Surg</source><year>2017</year><volume>32</volume><issue>2</issue><fpage>83</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">28492788</pub-id></element-citation></ref></ref-list></back></article>